Stockholders’ Equity (Tables)

9 Months Ended

Apr. 30, 2023

Stockholders’ Equity [Abstract]

Schedule of summarizes restricted stock unit (“RSU”) activity

	Three months ended April 30,				Nine months ended April 30,
	2023		2022		2023		2022
Stock options and performance stock units	$	286	$	76	$	842	$	898
Restricted stock units		277		86		666		159
	$	563	$	162	$	1,508	$	1,057

Schedule of expense related to share-based payment arrangements

	Three months ended April 30,				Nine months ended April 30,
	2023		2022		2023		2022
Selling, general and administrative	$	547	$	158	$	1,450	$	1,037
Cost of revenues		16		4		58		20
	$	563	$	162	$	1,508	$	1,057

Schedule of stock option activity

	Options			Weighted Average Exercise Price		Weighted Average Remaining Contractual Term		Aggregate Intrinsic Value (000s)
Outstanding at July 31, 2022		3,941,783		$	3.00
Awarded		615,000		$	2.00
Exercised		(6,667	)		2.14			$
Cancelled or expired		(453,616	)	$	3.95
Outstanding at end of period		4,096,500		$	2.74		2.2 years	$	675
Exercisable at end of period		2,126,067		$			0.3 years	$

Schedule of PSU’s granted and outstanding

Grant Date	Total Grant		Forfeitures			Outstanding		Fair Market Value At Grant Date (000s)
10/19/2020		98,600		(40,300	)		58,300	$	122

Schedule of summarizes restricted stock unit (“RSU”) activity

	Number of Unvested RSUs  outstanding			Weighted Average Fair Value per Unit at Date of Grant or Vesting		Weighted Average Remaining Contractual Term	Aggregate Intrinsic Value (000s)
Outstanding at July 31, 2022		502,187		$	2.95
Granted		325,564			1.53
Vested		(145,263	)		3.06
Cancelled		—			$
Outstanding at end of period		682,488		$	2.25	1.1 years	$	1,727
Expected to vest at end of period		682,488		$		1.1 years	$